Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia
Psychiatric Services - United States
doi 10.1176/appi.ps.201700398
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
American Psychiatric Association Publishing